Results
|
33361.
|
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. [electronic resource] by
- Ladenstein, Ruth
- Pötschger, Ulrike
- Valteau-Couanet, Dominique
- Luksch, Roberto
- Castel, Victoria
- Yaniv, Isaac
- Laureys, Genevieve
- Brock, Penelope
- Michon, Jean Marie
- Owens, Cormac
- Trahair, Toby
- Chan, Godfrey Chi Fung
- Ruud, Ellen
- Schroeder, Henrik
- Beck Popovic, Maja
- Schreier, Guenter
- Loibner, Hans
- Ambros, Peter
- Holmes, Keith
- Castellani, Maria Rita
- Gaze, Mark N
- Garaventa, Alberto
- Pearson, Andrew D J
- Lode, Holger N
Producer: 20190617
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|
|
33362.
|
|
|
33363.
|
|
|
33364.
|
|
|
33365.
|
|
|
33366.
|
|
|
33367.
|
|
|
33368.
|
|
|
33369.
|
|
|
33370.
|
|
|
33371.
|
|
|
33372.
|
|
|
33373.
|
|
|
33374.
|
|
|
33375.
|
|
|
33376.
|
|
|
33377.
|
|
|
33378.
|
|
|
33379.
|
Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells. [electronic resource] by
- Tian, Jun
- Raffa, Fatmah Al
- Dai, Meiou
- Moamer, Alaa
- Khadang, Baharak
- Hachim, Ibrahim Y
- Bakdounes, Khldoun
- Ali, Suhad
- Jean-Claude, Bertrand
- Lebrun, Jean-Jacques
Producer: 20190828
In:
British journal of cancer vol. 119
Availability: No items available.
|
|
33380.
|
|